US › Healthcare

Amarin Corporation PLC (AMRN)

US · Healthcare · Drug Manufacturers - General

$14.40+1.84%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$43.3M
Revenue YoY
+3.1%
Net profit
$-10.5M
Profit YoY
+33.0%
EPS
$-0.03
EPS estimate
$-0.21
Net margin
-24.3%

EPS came in at -0.03 against a street estimate of -0.21 — a beat of 85.7%.

Key statistics

Market cap
$296.5M
Forward P/E
500.0
P/B
0.68
Book value
$21.12
EPS (TTM)
$-1.20
52-week high
$20.90
52-week low
$12.96
50-day MA
$14.81
200-day MA
$15.19
Beta
0.77

Analyst view

Analysts rate Amarin Corporation PLC a sell (0 buy, 1 hold, 2 sell out of 3) with an average price target of $12.00.

Shareholding

Insiders
37.91%
Institutions
22.88%

Largest institutional holders

FundStake
Sarissa Capital Management LP7.98%
Acadian Asset Management LLC3.04%
Kynam Capital Management, LP2.25%
Millennium Management LLC1.43%
Morgan Stanley - Brokerage Accounts1.40%
Point72 Asset Management, L.P.1.15%
Waterfront Wealth Inc.0.97%
Eversept Partners, LP0.70%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Amarin Corporation PLC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.